Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sercan Aksoy

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
World Journal of Gastroenterology|January 27, 2016
Targeted therapies in gastric cancer and future perspectivesOzan Yazici, M Ali Nahit Sendur, Nuriye Ozdemir, et al.
Cancers|May 25, 2024
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Alessandro Rizzo, Sercan Aksoy, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 10, 2005
Doxorubicin-induced second degree and complete atrioventricular blockSaadettin Kilickap, Ebru Akgul, Sercan Aksoy, et al.
Cancer Treatment Reviews|May 14, 2025
Drug-Drug interactions and special considerations in breast cancer patients treated with CDK4/6 inhibitors: A comprehensive reviewTaha Koray Sahin, Gozde Kavgaci, Deniz Can Guven, et al.
Cancer Treatment Reviews|March 23, 2025
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancerTaha Koray Sahin, Alessandro Rizzo, Deniz Can Guven, et al.
Medical Hypotheses|June 20, 2006
Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancerSercan Aksoy, Hatice Aksoy, Hakan Harputluoglu, et al.
Clinical Breast Cancer|November 30, 2017
The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on SurvivalYusuf Karakas, Omer Dizdar, Sercan Aksoy, et al.
Indian Journal of Pharmacology|February 20, 2014
Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinomaMehmet A N Sendur, Sercan Aksoy, Nuriye Yıldırım Özdemir, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|November 8, 2013
Clinicopathologic features of gastric cancer in young patientsMetin Seker, Sercan Aksoy, Nuriye Y Ozdemir, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2012
Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patientsDidem Sener Dede, Sercan Aksoy, Mustafa Cengiz, et al.
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
World Journal of Gastroenterology|January 27, 2016
Targeted therapies in gastric cancer and future perspectivesOzan Yazici, M Ali Nahit Sendur, Nuriye Ozdemir, et al.
Cancers|May 25, 2024
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Alessandro Rizzo, Sercan Aksoy, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 10, 2005
Doxorubicin-induced second degree and complete atrioventricular blockSaadettin Kilickap, Ebru Akgul, Sercan Aksoy, et al.
Cancer Treatment Reviews|May 14, 2025
Drug-Drug interactions and special considerations in breast cancer patients treated with CDK4/6 inhibitors: A comprehensive reviewTaha Koray Sahin, Gozde Kavgaci, Deniz Can Guven, et al.
Cancer Treatment Reviews|March 23, 2025
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancerTaha Koray Sahin, Alessandro Rizzo, Deniz Can Guven, et al.
Medical Hypotheses|June 20, 2006
Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancerSercan Aksoy, Hatice Aksoy, Hakan Harputluoglu, et al.
Clinical Breast Cancer|November 30, 2017
The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on SurvivalYusuf Karakas, Omer Dizdar, Sercan Aksoy, et al.
Indian Journal of Pharmacology|February 20, 2014
Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinomaMehmet A N Sendur, Sercan Aksoy, Nuriye Yıldırım Özdemir, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|November 8, 2013
Clinicopathologic features of gastric cancer in young patientsMetin Seker, Sercan Aksoy, Nuriye Y Ozdemir, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2012
Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patientsDidem Sener Dede, Sercan Aksoy, Mustafa Cengiz, et al.
Pageof 21